Host and HBV Interactions and Their Potential Impact on Clinical Outcomes

Immune response during HBV infection. (A) Cytokine-mediated hepatocyte death: (1) In this process, HBV cccDNA generates multiple RNA lineages. (2) These RNAs are transported to the cytoplasm to synthesize viral antigens, including core (HBsAg), surface (HBsAg), and e antigens (HBeAg). (3) Proteasomes cleave these antigens, creating peptides recognized by pattern recognition receptors. (5–7) Activation of these receptors triggers interferon transcription and translation pathways. (8–10) Secreted interferons activate resident phagocytes and natural killer cells (NK cells). (4) CD8 lymphocytes (CD8 T cells) can be activated by the major histocompatibility complex class I (MHC-I), specifically human leukocyte antigen-A2 (HLA-A2) subtype, presenting the peptides produced by the proteasome. (11) Immune cells produce cytokines that initiate apoptosis through cytoplasmic and nuclear pathways. (12) The nuclear pathway starts with perforin release, forming channels in the cell membrane for granzymes to enter the cytoplasm. Granzymes affect mitochondria, generating reactive oxygen species (ROS). (13) Elevated ROS levels trigger the release of the SET complex from the endoplasmic reticulum. (14) The SET complex contains endonuclease domains, facilitating DNA cleavage in the nucleus to aid apoptosis. (15) The cytoplasmic pathway is mainly initiated by the interaction between the soluble Fas ligand (SFasL) and Fas surface receptor (Fas) in the serum. This interaction involves recruiting adapter proteins like Fas-associated death domain (FADD). FADD then activates caspase-8, which activates downstream effector caspases, including caspase-3. (16) Caspases target specific proteins, called apoptotic substrates, which lead to cellular dismantling. (B) Viral particle neutralization in the bloodstream: (1) Viruses released from infected hepatocytes are captured and processed by bloodstream phagocytes. (2) Processed peptides are presented by MHC-class II to CD4 T cells, resulting in IL-21 release. (3–5) IL-21 induces B cell differentiation into plasma cells, producing primary antibodies against HBV infection. Abbreviations: IgM anti-HBc: immunoglobulin M antibodies against hepatitis B core antigen. IgG anti-HBc: immunoglobulin G antibodies against hepatitis B core antigen. IgG anti-HBs: immunoglobulin G antibodies against hepatitis B surface antigen. IgG anti-HBe: immunoglobulin G antibodies against hepatitis B e antigen.
Host and HBV Interactions and Their Potential Impact on Clinical Outcomes

Publication

Host and HBV Interactions and Their Potential Impact on Clinical Outcomes. (2023) Alexis Jose-Abrego, et al. Pathogens. 2023 Sep;12(9):1146. Figure: F2.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Homo sapiens Primates CD8 CD8 ncbigene_synonym CD8A 925
Homo sapiens Primates CD8 CD8 famplex_relations CD8B 926
Homo sapiens Primates Fas FAS ncbigene_symbol FAS 355
Homo sapiens Primates Fas FAS ncbigene_synonym FASN 2194
Homo sapiens Primates SET SET ncbigene_symbol SET 6418
Homo sapiens Primates Nucl NUC1 ncbigene_synonym PPARD 5467
Homo sapiens Primates IFNs IFN ncbigene_synonym IFNA1 3439
Homo sapiens Primates IgM IGM ncbigene_synonym CD40LG 959
Homo sapiens Primates particles PARTICLE ncbigene_synonym PARTICL 100630918
Homo sapiens Primates CD4 CD4 ncbigene_symbol CD4 920

Chemical mentions

Word Match MeSH Name ChEBI
HBcAg HBsAg HBeAg Silver mesh:D012834 silver(0) chebi:9141
HBsAg NA mesh:D006514

Disease mentions

Word Match MeSH Name DOID